Iridex (IRIX) Receivables - Other (2022 - 2023)
Iridex's (IRIX) quarterly Receivables - Other came in at $3.8 million in Q2 2023, up 12.29% year-on-year from $3.4 million in Q2 2022, and up 8.17% quarter-over-quarter from $3.5 million in Q4 2022.
Iridex (IRIX) Receivables - Other (2022 - 2023) Analysis & Trends
Iridex's Receivables - Other history runs 2 years deep, the most recent figure standing at $3.8 million for Q2 2023.
- On a quarterly basis, Receivables - Other rose 12.29% year-over-year to $3.8 million in Q2 2023; TTM through Apr 2023 was $3.8 million, a 12.29% increase from a year earlier, with the FY2022 full-year figure at $3.5 million, up 13.94% from the prior year.
- Receivables - Other grew to $3.8 million in Q2 2023 per IRIX's latest filing, from $3.5 million in the prior quarter.
- Across five years, Receivables - Other topped out at $3.8 million in Q2 2023 and bottomed at $2.4 million in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Iridex | 15.93 Mn | 11.33 Mn | 4.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 1, 2023 | 3.83 Mn |
| Apr 1, 2023 | 3.83 Mn |
| Dec 31, 2022 | 3.54 Mn |
| Dec 31, 2022 | 3.54 Mn |
| Oct 1, 2022 | 3.59 Mn |
| Oct 1, 2022 | 3.59 Mn |
| Jul 2, 2022 | 2.43 Mn |
| Jul 2, 2022 | 2.43 Mn |
| Apr 2, 2022 | 3.41 Mn |
| Apr 2, 2022 | 3.41 Mn |
| Jan 1, 2022 | 3.11 Mn |
| Jan 1, 2022 | 3.11 Mn |